Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Greg Hather

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Clinical and Translational Science|January 13, 2019
Evaluation of Wearable Digital Devices in a Phase I Clinical TrialElena S Izmailova, Ian L McLean, Gaurav Bhatia, et al.
Vaccines|April 28, 2023
Heterogeneity in Vaccinal Immunity to SARS-CoV-2 Can Be Addressed by a Personalized Booster StrategyMadison Stoddard, Lin Yuan, Sharanya Sarkar, et al.
Vaccines|May 7, 2025
The Impact of Vaccination Frequency on COVID-19 Public Health Outcomes: A Model-Based AnalysisLin Yuan, Madison Stoddard, Sharanya Sarkar, et al.
Clinical and Translational Science|August 1, 2019
Continuous Monitoring Using a Wearable Device Detects Activity-Induced Heart Rate Changes After Administration of AmphetamineElena S Izmailova, Ian L McLean, Greg Hather, et al.
Scientific Reports|February 28, 2020
Complete Protection in Macaques Conferred by Purified Inactivated Zika Vaccine: Defining a Correlate of ProtectionGinger Young, Kelly J Bohning, Melissa Zahralban-Steele, et al.
Cancer Research|October 27, 2012
Novel DNA damage checkpoints mediating cell death induced by the NEDD8-activating enzyme inhibitor MLN4924Jonathan L Blank, Xiaozhen J Liu, Katherine Cosmopoulos, et al.
The Journal of Infectious Diseases|June 30, 2022
Specificity and Breadth of the Neutralizing Antibody Response to a Live-Attenuated Tetravalent Dengue VaccineChristina R DeMaso, Lovkesh Karwal, Melissa Zahralban-Steele, et al.
Molecular Cancer Therapeutics|March 28, 2014
Nedd8-activating enzyme inhibitor MLN4924 provides synergy with mitomycin C through interactions with ATR, BRCA1/BRCA2, and chromatin dynamics pathwaysKhristofer Garcia, Jonathan L Blank, David C Bouck, et al.
Plos One|December 29, 2015
KRAS Genotype Correlates with Proteasome Inhibitor Ixazomib Activity in Preclinical In Vivo Models of Colon and Non-Small Cell Lung Cancer: Potential Role of Tumor MetabolismNibedita Chattopadhyay, Allison J Berger, Erik Koenig, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Clinical and Translational Science|January 13, 2019
Evaluation of Wearable Digital Devices in a Phase I Clinical TrialElena S Izmailova, Ian L McLean, Gaurav Bhatia, et al.
Vaccines|April 28, 2023
Heterogeneity in Vaccinal Immunity to SARS-CoV-2 Can Be Addressed by a Personalized Booster StrategyMadison Stoddard, Lin Yuan, Sharanya Sarkar, et al.
Vaccines|May 7, 2025
The Impact of Vaccination Frequency on COVID-19 Public Health Outcomes: A Model-Based AnalysisLin Yuan, Madison Stoddard, Sharanya Sarkar, et al.
Clinical and Translational Science|August 1, 2019
Continuous Monitoring Using a Wearable Device Detects Activity-Induced Heart Rate Changes After Administration of AmphetamineElena S Izmailova, Ian L McLean, Greg Hather, et al.
Scientific Reports|February 28, 2020
Complete Protection in Macaques Conferred by Purified Inactivated Zika Vaccine: Defining a Correlate of ProtectionGinger Young, Kelly J Bohning, Melissa Zahralban-Steele, et al.
Cancer Research|October 27, 2012
Novel DNA damage checkpoints mediating cell death induced by the NEDD8-activating enzyme inhibitor MLN4924Jonathan L Blank, Xiaozhen J Liu, Katherine Cosmopoulos, et al.
The Journal of Infectious Diseases|June 30, 2022
Specificity and Breadth of the Neutralizing Antibody Response to a Live-Attenuated Tetravalent Dengue VaccineChristina R DeMaso, Lovkesh Karwal, Melissa Zahralban-Steele, et al.
Molecular Cancer Therapeutics|March 28, 2014
Nedd8-activating enzyme inhibitor MLN4924 provides synergy with mitomycin C through interactions with ATR, BRCA1/BRCA2, and chromatin dynamics pathwaysKhristofer Garcia, Jonathan L Blank, David C Bouck, et al.
Plos One|December 29, 2015
KRAS Genotype Correlates with Proteasome Inhibitor Ixazomib Activity in Preclinical In Vivo Models of Colon and Non-Small Cell Lung Cancer: Potential Role of Tumor MetabolismNibedita Chattopadhyay, Allison J Berger, Erik Koenig, et al.
Pageof 2